Colorectal Cancer Trial, Recruiting (NCT05993923)

Colorectal Cancer Trial, Recruiting NCT05993923 Sponsor: Centre Hospitalier Universitaire de Nīmes Condition: Colorectal Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05993923 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Colorectal Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The patient, or someone representing them, must have agreed to take part and signed a consent form after being fully informed about the trial
The patient must be covered by a health insurance plan
The patient must have a confirmed diagnosis of colorectal cancer
The patient must be scheduled to have colorectal surgery at the University Hospital of Nîmes, with that surgery approved through a specialist digestive surgery review process following an assessment of their age-related health needs
The planned surgery must involve removing the affected section of bowel and reconnecting it in a single operation

Who may not be able to join:

People who are already taking part in another interventional research study that could interfere with the main results of this trial (confirm with trial site)
People who are unable to understand or receive information about the trial in a meaningful way
People who are under legal protection orders, such as court-appointed guardianship or a justice safeguard measure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Coralie Labarias, CHU de Nimes

Phone: 04.66.68.79.46

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05993923

Sponsor: Centre Hospitalier Universitaire de Nīmes

Phase: Not Applicable

Status: Recruiting

Condition: Colorectal Cancer

Trial contact: 04.66.68.79.46

More information: https://clinicaltrials.gov/study/NCT05993923

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The patient, or someone representing them, must have agreed to take part and signed a consent form after being fully informed about the trial
The patient must be covered by a health insurance plan
The patient must have a confirmed diagnosis of colorectal cancer
The patient must be scheduled to have colorectal surgery at the University Hospital of Nîmes, with that surgery approved through a specialist digestive surgery review process following an assessment of their age-related health needs
The planned surgery must involve removing the affected section of bowel and reconnecting it in a single operation

Who may not be able to join:

People who are already taking part in another interventional research study that could interfere with the main results of this trial (confirm with trial site)
People who are unable to understand or receive information about the trial in a meaningful way
People who are under legal protection orders, such as court-appointed guardianship or a justice safeguard measure

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre Hospitalier Universitaire de Nīmes

Registry

ClinicalTrials.gov

Start date

26 September 2023

Est. completion

1 October 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Change in functional status after colorectal cancer surgery between groups

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov